Happy Lunar New Year
乔治临床( George Clinical ) in China would like to wish all of our clients, sponsors and investigators the best wishes for Lunar New Year. […]
了解更多
乔治临床( George Clinical ) in China would like to wish all of our clients, sponsors and investigators the best wishes for Lunar New Year. […]
了解更多
A diabetes epidemic is upon us, despite improved knowledge and therapy on this disease. The recently published 6th edition of the International Diabetes Federation Atlas provides some alarming figures.
了解更多
It is an exciting time as risk-based monitoring (RBM) application grows throughout industry. […]
了解更多
There’s no better time to be working with us. The Australian Tax Office will provide a tax incentive to encourage R&D activities in Australia, jointly administered by AusIndustry. Companie […]
了解更多
The 乔治临床( George Clinical ) Data Management group offers end to end Data Management services for phase I – IV and post-marketing clinical trials, as well as tailored services for academic rese […]
了解更多
Cinacalcet is a drug that lowers levels of parathyroid hormone, a factor that is increased in almost all people with kidney failure and has been linked to an increased risk of fracture, cardio […]
了解更多
In order to meet the growing needs of our customers, 乔治临床( George Clinical ) has expanded its geographical footprint within Asia. In 2012 we saw the opening of a second 乔治临床( George Clinical ) […]
了解更多
乔治临床( George Clinical ) China has appointed a new General Manager to lead its growing operation in China as it seeks to provide a stronger platform for delivering clinical trials across the As […]
了解更多
Emeritus Professor Norbert Berend, internationally recognised for his work on chronic obstructive pulmonary disease, has been appointed Head of Respiratory Research at 乔治临床( George Clinical ). […]
了解更多
Adding another milestone to our history of success and growth, 乔治临床( George Clinical ) have established an office in Bangalore, India. […]
了解更多
